Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
41.2%
% of IHE's 34 holdings also in FTXH
28.0%
% of FTXH's 51 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 22.3% | 6.9% | 6.9% |
|
MERCK & CO. INC. | 4.8% | 7.4% | 4.8% |
|
PFIZER INC | 4.6% | 7.3% | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 7.4% | 4.5% |
|
ELI LILLY & CO | 23.4% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 19.6% |
|
JOHNSON & JOHNSON | 15.4% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
CATALENT INC | 4.2% |
|
ELANCO ANIMAL HEALTH, INC. | 2.3% |
|
INTRA-CELLULAR THERAPIES INC | 2.0% |
|
ZOETIS INC | 1.1% |
|
AXSOME THERAPEUTICS, INC. | 1.1% |
|
VIATRIS, INC. | 1.0% |
|
CORCEPT THERAPEUTICS INC | 0.9% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -7.1% |
|
AMGEN INC | -3.6% |
|
CARDINAL HEALTH INC | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
GILEAD SCIENCES INC | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -2.9% |
|
PFIZER INC | -2.8% |